Molecular diagnosis of ectopic pregnancy

Expert Review of Molecular Diagnostics

Volumn 11, Issue 8, 2011, Pages 759-762

  Barnhart, Kurt ^a   Speicher, David W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

ADAM 12; diagnostic test; ectopic pregnancy; proteomics

Indexed keywords

ADAM PROTEIN; BIOLOGICAL MARKER; ESTRADIOL; HUMAN PLACENTA LACTOGEN; INHIBIN A; INTERLEUKIN 6; INTERLEUKIN 8; ISTHMIN 2; MUCIN 1; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROGESTERONE; PROTEIN ADAM12; PROTEOME; RELAXIN; RENIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECTOPIC PREGNANCY; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; MINIMALLY INVASIVE PROCEDURE; MOLECULAR DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADAM PROTEINS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MEMBRANE PROTEINS; MOLECULAR DIAGNOSTIC TECHNIQUES; PREGNANCY; PREGNANCY, ECTOPIC;

EID: 80054965259     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.72     Document Type: Editorial

References (24)

1. Hoover KW, Tao G, Kent CK. Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstet. Gynecol. 115, 495-502 (2010).
2. Barnhart KT. Ectopic pregnancy. N. Engl. J. Med. 361, 79-87 (2009).
3. Seeber BE, Barnhart KT. Suspected ectopic pregnancy. Obstet. Gynecol. 107, 399-413 (2006) (2 Pt 1). Erratum: Obstet. Gynecol. 107(4), 955 (2006).
4. Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors of disease. Mutat. Res. 480-481, 349-358 (2001).
5. McMichael AJ, Hall AJ. The use of biological markers as predictive early-outcome measures in epidemiological research. In: Application of Biomarkers in Cancer Epidemiology. Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N (Eds). WHO Press, Geneva, Switzerland, 281-289 (1997).
6. Hall JA, Brown R, Paul J. An exploration into study design for biomarker identification: issues and recommendations. Cancer Genomics Proteomics 4, 111-120 (2007).
7. Pepe MS, Etzioni R, Feng AZ et al. Phases of biomarker development for early detection of cancer. J. Natl Cancer Inst. 93, 1054-1061 (2001).
8. Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemol. Biomark. Prev. 4, 301-311 (1995).
9. Cartwright J, Duncan WC, Critchley HOD, Horne AW. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities. Reproduction 138, 9-22 (2009).
10. Rausch ME, Sammel M, Takacs P, Chung K, Shaunik A, Barnhart K. Development of a multiple marker test for the accurate diagnosis of an ectopic pregnancy. Obstet. Gynecol. 117, 573-582 (2011).
11. Horne AW, Duncan WC, Critchley HOD. The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy. Acta Obstet. Gynecol. Scand. 89, 299-301 (2010).
12. Horne AW, van den Driesche S, Critchley HO et al. Endometrial inhibin/activin b-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J. Clin. Endocrinol. Metab. 93, 2375-2382 (2008).
13. Horne AW, Shaw JL, Murdoch A et al. Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy. J. Clin. Endocrinol. Metab. 96, E104-E108 (2011).
14. Savaris RF, Carlos da Silva L, da Silva Moraes G, Albano Edelweiss MI. Expression of MUC1 in tubal pregnancy. Fertil. Steril. 89, 1015-1017 (2008).
15. Al-Azemi M, Refaat B, Aplin J, Ledger W. The expression of MUC1 in human fallopian tube during the menstrual cycle and in ectopic pregnancy. Hum. Reprod. 24(10), 2582-2587 (2009).
16. Seeber B, Sammel MD, Fan X, Gerton G, Shaunik A, Chittams J, Barnhart K. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil. Steril. 89, 1973-1081 (2008).
17. Soriano D, Hugol D, Quang NT, Darai E. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor a in patients with ectopic pregnancy. Fertil. Steril. 79, 975-980 (2003).
18. Mueller MD, Raio L, Spoerri S, Ghezzi F, Dreher E, Bersinger NA. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy. Fertil. Steril. 81, 1106-1111 (2004).
19. Condous G, Kirk E, Syed A et al. Do levels of serum cancer antigen 125 and creatine kinase predict the outcome in pregnancies of unknown location? Hum. Reprod. 20, 3348-3354 (2005).
20. Phipps GM, Hogan WJ, Peipert FJ. Progesterone, inhibin, and hCG. Multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet. Gynecol. 95, 227-231 (2000).
21. Beer LA, Tang, HY, Sriswasdi S, Barnhart KT, Speicher DW. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J. Proteome Res. 10, 1126-1138 (2011).
22. Beer LA, Tang HY, Barnhart KT, Speicher DW. Plasma biomarker discovery using 3-D protein profiling coupled with label-free quantitation. Methods Mol. Biol. 728, 3-27 (2011).
23. Tang HY, Beer LA, Barnhart KT, Speicher DW. Rapid verification of candidate serological biomarkers using gel-based label-free multiple reaction monitoring. J. Proteome Res. 10(9), 4005-4017 (2011).
24. Rausch ME, Beer L, Sammel M et al. disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil. Steril. 95, 1373-1378 (2011).